CH5138303, with the CAS number 959763-06-5, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. It is characterized as a small molecule with a specific structure that allows it to interact with biological targets, making it a candidate for drug development. The compound typically exhibits properties such as solubility in organic solvents, moderate stability under standard conditions, and a defined mechanism of action related to its target pathways. Its efficacy and safety profile would be evaluated through various preclinical and clinical studies, focusing on its pharmacokinetics, pharmacodynamics, and potential side effects. As with many compounds in drug discovery, the characteristics of CH5138303, including its biological activity and interaction with cellular systems, are critical for understanding its potential use in treating specific diseases or conditions. Further research is essential to fully elucidate its properties and therapeutic potential.

CH5138303

959763-06-5: CH5138303, with the CAS number 959763-06-5, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. It is characterized as a small molecule with a specific structure that allows it to interact with biological targets, making it a candidate for drug development. The compound typically exhibits properties such as solubility in organic solvents, moderate stability under standard conditions, and a defined mechanism of action related to its target pathways. Its efficacy and safety profile would be evaluated through various preclinical and clinical studies, focusing on its pharmacokinetics, pharmacodynamics, and potential side effects. As with many compounds in drug discovery, the characteristics of CH5138303, including its biological activity and interaction with cellular systems, are critical for understanding its potential use in treating specific diseases or conditions. Further research is essential to fully elucidate its properties and therapeutic potential.

4-((4-amino-6-(5-chloro-1,3-dihydrobenzo[de]isochromen-6-yl)-1,3,5-triazin-2-yl)thio)butanamide

CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.

CAS 959763-06-5

CH5138303

4-((4-amino-6-(5-chloro-1,3-dihydrobenzo[de]isochromen-6-yl)-1,3,5-triazin-2-yl)thio)butanamide

Ref: IN-DA01DP0G

CH5138303

Ref: TM-T6442